Follow this blog:
RSS

Will individual data control entice people to enter clinical trials?

By | March 15, 2013, 9:23 AM PDT

If you had control over biomedical research and how your data was used, would you be more inclined to participate in medical trials?

The usual way — the long-winded consent form, and perhaps a few dollars for your time — doesn’t seem to be working. Biomedical scientists often struggle to rouse enough interest and recruit enough patients to make studies happen, and so a pilot project aimed at bringing patient and doctor together has been launched.

Nonprofit Genetic Alliance has revealed a new website called Reg4All, which allows patients to fine-tune just how their data is used — from sharing it only with particular researchers and institutions to tracking studies and monitoring how and when their information is used.

It is hoped that the system will not only increase patient privacy, but will also help expand biomedical research. By reaching out to patients online, perhaps participating in clinical trials — especially when you’re looking for experimental treatments for uncommon diseases — will become a clearer, less confusing process.

Krishanu Saha, a stem cell engineer at the University of Wisconsin-Madison, believes that people will be more interested in research if they have control over its elements.

“More than just disclosure, a true partnership would involve some sharing of power.”

Reg4All was funded in part by a $300,000 award from the American Liver Foundation. The CEO of the ALF is also planning to trial a project which will place liver disease patients into the Reg4All system.

Continue reading: Technology Review

Image credit: Alex Proimos

Related:

Start your week smarter with our weekly e-mail newsletter. It's your cheat sheet for good ideas. Get it.

Charlie Osborne

About Charlie Osborne

Charlie Osborne is a contributing editor for SmartPlanet.

Charlie Osborne

Charlie Osborne

Contributing Editor

Charlie Osborne is a freelance journalist and graphic designer based in London. In addition to SmartPlanet, she also writes the iGeneration column for business technology website ZDNet. She holds degrees in medical anthropology from the University of Kent.

Follow her on Twitter.

Charlie Osborne

Charlie Osborne

Charlie Osborne does not have financial holdings that would influence how or what she covers.

She writes for SmartPlanet and is not an employee of CBS.

If you liked this, don't miss...
The discussion hasn’t started yet. Why don’t you begin it?
Formatting +
BB Codes - Note: HTML is not supported in forums
  • [b] Bold [/b]
  • [i] Italic [/i]
  • [u] Underline [/u]
  • [s] Strikethrough [/s]
  • [q] "Quote" [/q]
  • [ol][*] 1. Ordered List [/ol]
  • [ul][*] · Unordered List [/ul]
  • [pre] Preformat [/pre]
  • [quote] "Blockquote" [/quote]

Join the SmartPlanet community and join the conversation! Signing up is fast and free. Don't wait -- we want to hear your opinion!